Skip to main content
SpringerLink
Log in
Book cover

Anticancer Drug Discovery and Development: Natural Products and New Molecular Models

Proceedings of the Second Drug Discovery and Development Symposium Traverse City, Michigan, USA — June 27–29, 1991

  • Conference proceedings
  • © 1994

Overview

Editors:
  1. Frederick A. Valeriote

    1. School of Medicine, Wayne State University, Detroit, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Thomas H. Corbett

    1. School of Medicine, Wayne State University, Detroit, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  3. Laurence H. Baker

    1. School of Medicine, Wayne State University, Detroit, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Developments in Oncology (DION, volume 74)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (17 papers)

  1. Front Matter

    Pages i-xi
    Download chapter PDF

  2. Discovery of Natural Products from Microalgae and Marine Organisms

    • Fred Valeriote, Richard E. Moore, Gregory M. L. Patterson, Valerie J. Paul, Paul J. Scheuer, Thomas Corbett
    Pages 1-25

  3. Discovery of Naturally Occurring Antitumor Agents

    • Ching-Jer Chang, Curtis L. Ashendel, Robert L. Geahlen, Jerry L. McLaughlin
    Pages 27-37

  4. Marine Invertebrates and Microbes as Sources of Potential Antitumor Compounds

    • Andrew L. Staley, Jon Clardy
    Pages 39-61

  5. Novel Strategies for the Discovery of Plant-Derived Anticancer Agents

    • Geoffrey A. Cordell, Norman R. Farnsworth, Christopher W. W. Beecher, D. Doel Soejarto, A. Douglas Kinghorn, John M. Pezzuto et al.
    Pages 63-83

  6. A Strategy for Identifying Novel Inhibitors of DNA Topoisomerase I

    • Sidney M. Hecht, David E. Berry, Laurie J. Mackenzie, Elva A. Shultis, James A. Chan
    Pages 85-94

  7. Altromycins: A New Family of Antitumor Antibiotics-Discovery and Biological Evaluation

    • J. B. McAlpine, J. P. Karwowski, M. Jackson, G. M. Brill, S. Kadam, L. Shen et al.
    Pages 95-117

  8. Suppression of Human Melanoma Metastasis in SCID Mice with Antibodies to the EGF-Receptor

    • B. M. Mueller, R. A. Reisfeld
    Pages 119-125

  9. Growth Factor and Oncogene Signalling as a Target for Anticancer Drug Development

    • Garth Powis
    Pages 127-148

  10. Nucleoside and Nucleotide Modulation of Oncogenic Expression: A New Approach to Cancer Chemotherapy

    • Roland K. Robins, Rick A. Finch, Thomas L. Avery
    Pages 149-182

  11. Interferons in Cancer Therapy: From Clinical Trials to New Potentials in Anticancer Drug Discovery and Development

    • Gerhard G. Steinmann, Gunther R. Adolf, Gerhard Leitz
    Pages 183-208

  12. Selection and Manipulation of Immunoglobulins for Radionuclide Delivery

    • Z. Steplewski, P. Curtis, J. Hainfeld, R. Mease, S. Srivastava
    Pages 209-233

  13. Microorganisms: Strategic Sources of Novel Antitumor Agents

    • Josefino B. Tunac
    Pages 235-267

  14. The Therapeutic Potential of Novel Pure Antiestrogens

    • A. E. Wakeling
    Pages 269-282

  15. Preclinical Pharmacology and Phase I Clinical Trials of TaxotereR (RP 56976, NSC 628503)

    • Marie-Christine Bissery, Howard Burris, Richard Pazdur
    Pages 283-297

  16. Bropirimine, a Small-Molecule Biological Response Modifier and an Effective Antitumor Agent

    • Li H. Li
    Pages 299-345

  17. Determinants of Etoposide Cytotoxicity in Vitro

    • Richard B. Lock
    Pages 347-363

  18. Screening for Anticancer Leads from Marine Organisms in a Mechanism-Based Drug Discovery Program

    • P. Crews, D. L. Slate, W. H. Gerwick, F. J. Schmitz, R. Schatzman, B. Strulovici et al.
    Pages 365-403
Back to top

Keywords

About this book

With the publication of these proceedings from the Second Drug Discovery and Development Symposium, this forum has become the main mechanism for bringing together the principal groups involved in both discovering and developing new approaches to the treatment of cancer. This Second Symposium emphasized the types of materials being discovered and their therapeutic activity. This is especially evident in the natural product discovery programs, where unique and active structures are being identified.
The major contributors to the meeting were the investigators participating in the National Cooperative (Natural Products) Drug Discovery Groups [NC(NP)DDG]. These groups reflect an association among researchers at universities or cancer centers, pharmaceutical companies and the National Cancer Institute. Their sources of materials are varied, reflecting chemical inventories of pharmaceutical companies, organic synthetic compounds from the laboratory, cytotoxics as well as biologics and their hybrids, and natural products obtained from plants, marine organisms and microorganisms. The models employed in the discovery systems vary from broadly cellular based to specific enzymes to defined cellular functions. Each of them is believed important to the malignant state and will allow for the discovery of compounds which will have efficacy in cancer therapy.
The goal of the participants is both to discover new anticancer agents and to develop them as efficiently as possible into clinically useful additions to treatment. Of importance is the fact that there are a number of promising leads which will soon be moving into the clinic thereby testing the effectiveness of this NC (NP) DDG approach.

Editors and Affiliations

  • School of Medicine, Wayne State University, Detroit, USA

    Frederick A. Valeriote, Thomas H. Corbett, Laurence H. Baker

Bibliographic Information

  • Book Title: Anticancer Drug Discovery and Development: Natural Products and New Molecular Models

  • Book Subtitle: Proceedings of the Second Drug Discovery and Development Symposium Traverse City, Michigan, USA — June 27–29, 1991

  • Editors: Frederick A. Valeriote, Thomas H. Corbett, Laurence H. Baker

  • Series Title: Developments in Oncology

  • DOI: https://doi.org/10.1007/978-1-4615-2610-0

  • Publisher: Springer New York, NY

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer Science+Business Media New York 1994

  • Hardcover ISBN: 978-0-7923-2928-2Published: 31 July 1994

  • Softcover ISBN: 978-1-4613-6118-3Published: 08 October 2012

  • eBook ISBN: 978-1-4615-2610-0Published: 06 December 2012

  • Edition Number: 1

  • Number of Pages: XI, 403

  • Topics: Oncology, Cancer Research, Pharmacology/Toxicology

Publish with us

Policies and ethics

Back to top

Search

Navigation